Welcome to Shield Therapeutics
Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of secondary care-focused pharmaceuticals
Shield Therapeutics was voted the PM Society Awards Gold winner for Events and Exhibitions at the 2015 ECCO Symposium.
Shield Therapeutics Announces Successful Placing to Raise £32.5 Million and Proposed Admission to AIM| Feb 12 2016
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR…
Shield Therapeutics announces receipt of a positive opinion from the CHMP recommending the approval of Feraccru for the treatment of iron deficiency anaemia| Dec 18 2015
Shield Therapeutics plc today announces that the Committee for Medicinal Products for Human…